Abstract

Diabetic foot ulcers (DFU) are a predominant impediment among diabetic patients, increasing morbidity and wound care costs. There are various strategies including using biomaterials have been explored for the management of DFU. This paper will review the injectable hydrogel application as the most studied polymer-based hydrogel based on published journals and articles. The main key factors that will be discussed in chronic wounds focusing on diabetic ulcers include the socioeconomic burden of chronic wounds, biomaterials implicated by the government for DFU management, commercial hydrogel product, mechanism of injectable hydrogel, the current study of novel injectable hydrogel and the future perspectives of injectable hydrogel for the management of DFU.

Highlights

  • The skin is the body’s first defence mechanism as it acts as a shield from external pathogens and it initiates Vitamin D synthesis, thermal regulation and hydration

  • This phase is inaugurated by neutrophils, mast cells and macrophages causing the production of inflammatory cytokines (interleukin 1 (IL-1), tumour necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), and interferon-gamma (IFN-γ) besides the growth factors of platelet-derived growth factor (PDGF), transforming growth factor β (TGF-β), insulin-like growth factor 1 (IGF-1), and epidermal growth factor (EGF) that are the main essentials in the wound healing process [8]

  • These actions include the restoration of oxygen supply, the genesis of extracellular matrix (ECM) protein, vitronectin and collagen, proliferation and migration of fibroblast and keratinocytes that are the key essentials for the recovery of the integrity and functionality of the tissues [8]

Read more

Summary

Introduction

The skin is the body’s first defence mechanism as it acts as a shield from external pathogens and it initiates Vitamin D synthesis, thermal regulation and hydration. In contrast with chronic wounds, this type of wound involves a much more distorted healing process that can be classified as ulcers including all the others as pressure, venous, arterial, vascular and DFU. These chronic wounds demonstrate stalled inflammatory phase resulting in the development of biofilm, bacterial clusters, and elevation of protease at the site of the wound. Skin ulcers are often being related to diabetes, which is defined as the loss of the epithelium lining continuity, a dry type of stratified squamous epithelium (which causes the underlying tissue surface to be bare open). The interaction of cells, growth factors, and cytokines are involved in wound repair, which is a crucial part of the healing process

Wound Healing Phase
Phase 1
Phase 2
Phase 3
Phase 4
Chronic Wound Primary Contributor
Socioeconomic Burden of Chronic Wound
Current Treatment of Diabetic Foot Ulcer
Contraindications and Complications of Current Treatment
Tissue Engineering Advancement
Tissue-Derived Biomaterials
Hydrogel-Based Biomaterials
Commercialised Hydrogels for Diabetic Foot Management
Development of Injectable Hydrogel for Diabetic Foot Management
Mechanism of Injectable Hydrogel
Crosslinking Method
Physical Crosslinking
Chemical Crosslinking
Development of Injectable Hydrogel for Diabetic Ulcer Management
Development of pH-Sensitive Injectable Hydrogel
Development of Thermosensitive Injectable Hydrogel
Development of Multifunctional Injectable Hydrogel
Development of Hypoxic Injectable Hydrogel
Development of Self-Healing Injectable Hydrogel
Conclusion
Data Extraction Management
Conclusions
Findings
10. Future Perspectives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call